Overview

Dexmedetomine as Adjuvant for Spinal Anesthesia in Elective Cesarian Sections

Status:
Not yet recruiting
Trial end date:
2024-07-01
Target enrollment:
Participant gender:
Summary
The proposed study is a prospective, randomized, controlled, double-blind, single-center pilot study. The target population for the study will be adult pregnant women undergoing elective cesarean section under spinal anesthesia. This study will be carried out at a single site, the CHU Sainte-Justine as part of a research internship as part of the anesthesiology residency program at the University of Montreal. The aim of this pilot project is to evaluate the feasibility of a phase III study on the use of dexmedetomidine in intrathecal in the context of elective cesarean section and to demonstrate analgesia equivalent to the injection of opioids in intrathecal with lesser side effects.
Phase:
Phase 3
Details
Lead Sponsor:
St. Justine's Hospital
Treatments:
Dexmedetomidine